CD274 and neoplasm: Integrating CD274 (PD‐L1) expression enhanced prognostic stratification, with patients demonstrating low expression of the HLA‐DR+ tumor cell signature and low CD274 enjoying the most favorable survival outcomes (p = 0.028; Figure 5C).